Table 1.
Characteristics of individuals with prediabetes at baseline and at the time point of first manifestation of the corresponding complication (N=13,904).
|
|
Characteristics of individuals at baseline | Retinopathy | Nephropathy | Neuropathy | PVDa | CeVDb | CVDc | |||||||||
| Number of individuals, n | 13,904 | 35 | 753 | 58 | 258 | 462 | 544 | |||||||||
| Number of individuals without specific complication at/before baseline, n | N/Ad | 13,893 | 12,189 | 13,901 | 13,664 | 13,411 | 12,675 | |||||||||
| 5-year incidence (%) | N/A | 0.3 | 6.2 | 0.4 | 1.9 | 3.4 | 4.3 | |||||||||
| Demographic data | ||||||||||||||||
|
|
Sex, n (%) | |||||||||||||||
|
|
|
Female | 7412 (53.3) | 20 (57.1) | 392 (52.1) | 29 (50.0) | 107 (41.5) | 255 (55.2) | 188 (34.6) | |||||||
|
|
|
Male | 6492 (46.7) | 15 (42.9) | 361 (47.9) | 29 (50.0) | 151 (58.5) | 207 (44.8) | 356 (65.4) | |||||||
|
|
Age (years), mean (SD) | 51.2 (8.7) | 57.3 (8.7) | 58.0 (6.8) | 57.6 (8.5) | 59.8 (6.0) | 58.6 (7.2) | 57.4 (7.0) | ||||||||
|
|
BMI (kg/m2), mean (SD) | 30.0 (5.8) | 32.0 (5.1) | 31.4 (6.1) | 33.6 (6.8) | 30.2 (5.3) | 30.4 (5.0) | 30.9 (6.4) | ||||||||
|
|
SBPe (mmHg), mean (SD) | 124.8 (15.5) | 130.3 (17.0) | 128.9 (14.0) | 127.5 (14.0) | 128.7 (13.5) | 128.4 (13.1) | 128.5 (13.1) | ||||||||
|
|
DBPf (mmHg), mean (SD) | 77.8 (10.9) | 80.0 (6.9) | 78.8 (7.5) | 76.8 (7.7) | 78.7 (10.2) | 78.4 (7.7) | 78.5 (6.9) | ||||||||
| Biomarkers, mean (SD) | ||||||||||||||||
|
|
Glucose (mg/dL) | 97.5 (9.9) | 113.51 (14.48) | 103.15 (14.12) | 111.98 (16.23) | 102.46 (11.84) | 100.9 (14.11) | 100.77 (12.68) | ||||||||
|
|
HbA1cg (%) | 5.84 (0.26) | 6.28 (0.41) | 6.05 (0.57) | 6.36 (0.59) | 6.03 (0.41) | 5.97 (0.54) | 5.97 (0.46) | ||||||||
|
|
HbA1c (mmol/mol) | 40.41 (2.69) | 45.16 (4.58) | 42.57 (6.17) | 45.96 (6.52) | 42.39 (4.45) | 41.75 (5.81) | 41.78 (4.91) | ||||||||
aPVD: peripheral vascular disease.
bCeVD: cerebrovascular disease.
cCVD: cardiovascular disease.
dN/A: not applicable.
eSBP: systolic blood pressure.
fDBP: diastolic blood pressure.
gHbA1c: glycated hemoglobin.